Skip to Navigation Skip to Search Skip to Content
Search All Centers

Should I Join a Trial to Prevent Myeloma Progression?

Read Transcript Download/Print Transcript

Published on July 17, 2017

In this Ask the Expert clip, Patient Power viewer Janet asks about clinical trials for smoldering multiple myeloma patients. From Icahn School of Medicine at Mt. Sinai, Dr. Hearn Jay Cho discusses the viability of clinical trials and patient options.

This Ask the Expert series is a Patient Empowerment Network program produced by Patient Power. We thank Takeda and the Celgene Corporation for their support.

Featuring

Sponsors

Patient Empowerment Network

You might also like

Transcript | Should I Join a Trial to Prevent Myeloma Progression?

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That's how you’ll get care that's most appropriate for you.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you. 

Dr. Cho:

That's an excellent question.  This is an area of great interest from the research perspective, because we want to prevent progression to symptomatic disease, and there are a number of clinical trials that are out there right now.  I would encourage anyone with high?risk smoldering myeloma to discuss with their oncologist their options in terms of clinical trials.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you. 

You might also like